395 related articles for article (PubMed ID: 32190165)
1. Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(4):1-85. PubMed ID: 32190165
[TBL] [Abstract][Full Text] [Related]
2. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
[TBL] [Abstract][Full Text] [Related]
3. Bilateral Cochlear Implantation: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2018; 18(6):1-139. PubMed ID: 30443278
[TBL] [Abstract][Full Text] [Related]
4. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(14):1-148. PubMed ID: 33240455
[TBL] [Abstract][Full Text] [Related]
6. Osseointegrated Prosthetic Implants for People With Lower-Limb Amputation: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2019; 19(7):1-126. PubMed ID: 31911825
[TBL] [Abstract][Full Text] [Related]
7. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
8. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
Colletti L
Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
[TBL] [Abstract][Full Text] [Related]
9. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
10. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
[TBL] [Abstract][Full Text] [Related]
11. Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(8):1-188. PubMed ID: 34211617
[TBL] [Abstract][Full Text] [Related]
12. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
13. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
[TBL] [Abstract][Full Text] [Related]
14. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
[TBL] [Abstract][Full Text] [Related]
15. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
Ontario Health
Ont Health Technol Assess Ser; 2024; 24(2):1-162. PubMed ID: 38344326
[TBL] [Abstract][Full Text] [Related]
16. Internet-Delivered Cognitive Behavioural Therapy for Post-traumatic Stress Disorder or Acute Stress Disorder: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(9):1-120. PubMed ID: 34527087
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
[TBL] [Abstract][Full Text] [Related]
18. Auditory brainstem implants for neurofibromatosis type 2.
Colletti L; Shannon R; Colletti V
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
[TBL] [Abstract][Full Text] [Related]
19. 10-kHz High-Frequency Spinal Cord Stimulation for Adults With Chronic Noncancer Pain: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(6):1-109. PubMed ID: 32194881
[TBL] [Abstract][Full Text] [Related]
20. New outcomes with auditory brainstem implants in NF2 patients.
Behr R; Colletti V; Matthies C; Morita A; Nakatomi H; Dominique L; Darrouzet V; Brill S; Shehata-Dieler W; Lorens A; Skarzynski H
Otol Neurotol; 2014 Dec; 35(10):1844-51. PubMed ID: 25325841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]